Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
Allister Vale MD National Poisons Information Service PowerPoint Presentation
Download Presentation
Allister Vale MD National Poisons Information Service

Allister Vale MD National Poisons Information Service

145 Views Download Presentation
Download Presentation

Allister Vale MD National Poisons Information Service

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. DOES URINE ALKALINIZATION PREVENT OR REDUCE THE SEVERITY OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE IN POISONED PATIENTS? Allister Vale MD National Poisons Information Service (Birmingham Unit) and West Midlands Poisons Unit City Hospital, Birmingham, UK

  2. RHABDOMYOLYSIS • Aetiology • Diagnosis • Complications • Pathogenesis of rhabdomyolysis-induced renal failure • Rationale for urine alkalinization and volume replacement • Experimental and clinical studies

  3. RHABDOMYOLYSIS: AETIOLOGY • Trauma e.g. crush injuries • Drug-or other chemical-induced  Therapeutic  Poisoning Primary caused by direct insult Secondary e.g. local compression as a result of coma, seizures

  4. RHABDOMYOLYSIS: DIAGNOSIS • Dissolution of striated muscle fibres, with leakage of muscle enzymes, myoglobin and other intracellular constituents • Creatine kinase activity > 5x normal (CK-MB fraction < 5%) 2-12 hours after precipitating cause • Creatine kinase activity may continue to rise > 24 hours

  5. RHABDOMYOLYSIS: DIAGNOSIS • Transient increase in serum myoglobin soon after onset of rhabdomyolysis • Visible myoglobinuria (tea or coca-cola coloured urine) • Myoglobinuria >250 mg/L (normal < 0.5 mg/L) in presence of normal renal function

  6. RHABDOMYOLYSIS: DIAGNOSIS • Absence of myoglobinuria does not exclude diagnosis • Positive urine dipstick for haem but no red cells on microscopic examination of urine

  7. RHABDOMYOLYSIS: COMPLICATIONS • Acute renal failure • Nerve damage (compartment syndrome) • Hyperkalaemia (fatal dysrhythmias) • Hypocalcaemia (calcium binding by damaged muscle proteins and phosphates)

  8. RHABDOMYOLYSIS: COMPLICATIONS • Increase in plasma urate concentration (> 750 μmol/L) • Increase in serum phosphate concentration (>2.5 mmol/L) • Increase in AST/ALT activities • Increase in lactic dehydrogenase and aldolase (specific for muscle) activities

  9. RHABDOMYOLYSIS-INDUCED RENAL FAILURE • 5-30 % of patients with rhabdomyolysis develop acute renal failure (Gabow et al, 1982; Ward, 1988) • Rhabdomyolysis accounts for 5-9 % of all cases of acute renal failure (Grossman et al, 1974; Thomas and Ibels, 1985)

  10. URINE ALKALINIZATION AND RHABDOMYOLYSIS-INDUCED RENAL FAILURE • Bywaters et al, 1944 recommended the use of "alkaline diuresis" to prevent renal failure in patients with crush syndrome (Bywaters, 1990) • Since then, urine alkalinization has often been incorporated into treatment regimens • Is this management rational?

  11. PATHOGENESIS OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE • Tubular necrosis initiated by free-radical mediated lipid peroxidation • Renal vasoconstriction by several mechanisms • Tubular obstruction due to binding of free myoglobin to Tamm-Horsfall protein • Tubular obstruction due to hyperuricaemia • Compounded by hypovolaemia and aciduria

  12. PATHOGENESIS OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE 1.Tubular necrosis initiated by free-radical mediated lipid peroxidation • This involves redox cycling between two oxidation states of myoglobin haem: Fe3+ (ferric) and Fe4+ (ferryl) (Moore et al, 1998;Holt and Moore, 2000)

  13. PATHOGENESIS OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE 1.Tubular necrosis initiated by free-radical mediated lipid peroxidation • Ferryl (Fe4+) myoglobin can initiate lipid peroxidation • Its formation requires the presence of lipid hydroperoxides (LOOH)

  14. PATHOGENESIS OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE 1.Tubular necrosis initiated by free-radical mediated lipid peroxidation • Ferryl (Fe4+) myoglobin reacts with lipids (LH) and lipid hydroperoxides (LOOH) to form lipid alkyl (L.) and lipid peroxyl (LOO.) radicals • These radicals cause progressive tubular damage

  15. Moore et al, 1998

  16. PATHOGENESIS OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE 2. Renal vasoconstriction occursdue to: • Reduced circulating blood volume (hypovolaemia) • Activation of the sympathetic nervous system and renin-angiotensin system • Scavenging of the vasodilator, nitric oxide (NO), by myoglobin

  17. PATHOGENESIS OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE 2. Renal vasoconstriction occursdue to: • Release of isoprostanes formed as a result of free radical damage to phospholipid membranes • 15-F2t isoprostaneand 15-E2t isoprostaneare potent vasoconstrictors

  18. PATHOGENESIS OF RHABDOMYOLYSIS-INDUCED RENAL FAILURE 3.Tubular obstruction occurs due toformation of tubular casts • Formed by binding of free myoglobin to Tamm-Horsfall protein (Uromodulin), most abundant renal glycoprotein Zager, 1989 4.Tubular obstruction occurs due to urate crystal deposition (local inflammation)

  19. RATIONALE FOR URINE ALKALINIZATION Experimentally, urine alkalinization: • Suppresses the reactivity of ferryl (Fe4+) myoglobin • Inhibits the cyclical formation of lipid peroxide radicals and limits lipid peroxidation, so reducing tubular damage Moore et al, 1998

  20. RATIONALE FOR URINE ALKALINIZATION Experimentally: • Urine alkalinisation reduces isoprostane release thereby lessening vasoconstriction • Consistent with this, in isolated perfused kidneys, myoglobin induces vasoconstriction at acid pHHeyman et al, 1997

  21. RATIONALE FOR URINE ALKALINIZATION Experimentally: • Urine alkalinization reduces binding of myoglobin to Tamm-Horsfall protein Zager, 1989 • Urine alkalinization increases urate solubility Hediger et al, 2005 • Acidosisexacerbates myoglobin toxicity in isolated perfused kidneys

  22. RATIONALE FOR URINE ALKALINIZATION Experimentally: • Acute or chronic exogenous acid loads prevent renal damagein vivo • This may reflect a beneficial effect of any volume replacement or solute loadHeyman et al, 1997

  23. RATIONALE FOR URINE ALKALINIZATION Experimentally: • Administrationof a neutral non-reabsorbed soluteprevented:  renal retention of myoglobin renal damageto the same extent as urine alkalinization (pH ≥8) Zager, 1989

  24. URINE ALKALINIZATION: CLINICAL STUDIES • There are no adequately controlled studies • Two of the three studies involve traumatic rhabdomyolysis • Concomitant administration of mannitol in all three studies

  25. URINE ALKALINIZATION: CLINICAL STUDIES Eneas et al,1979 • Retrospective review of 20 patients with myoglobinuria (13/20 poisoned with drugs and alcohol) • All patients received crystalloid solutions until volume deficits were corrected

  26. URINE ALKALINIZATION: CLINICAL STUDIES Eneas et al,1979 • 17/20 were administered: Sodium bicarbonate 100 mEq in 1L 5% dextrose and mannitol 25 g  Infused at a rate of 250 mL/hr for 4 hr

  27. URINE ALKALINIZATION: CLINICAL STUDIES Eneas et al,1979 • 2/20 patients received intermittent injections of mannitol and sodium bicarbonate • 1/20 patients received mannitol alone • Supplemental infusions given in many cases

  28. URINE ALKALINIZATION: CLINICAL STUDIES Eneas et al,1979 • 9/20 had increased urine output following treatment (Responders) • Treatment commenced < 48 hours in all cases (5/9 < 24 hours) after admission • None required dialysis and all survived

  29. URINE ALKALINIZATION: CLINICAL STUDIES Eneas et al,1979 • 11/20 no increase in urine output after treatment (Non-responders) • Treatment commenced < 48 hours in all cases (6/11 < 24 hours) after admission • 10/11 required dialysis; one patient died

  30. URINE ALKALINIZATION: CLINICAL STUDIES Eneas et al,1979 • The non-responders had significantly:  Higher peak creatine kinase activities  Higher serum phosphate concentrations  Higher haematocrit

  31. URINE ALKALINIZATION: CLINICAL STUDIES Eneas et al,1979 • "These results demonstrate that some patients with myoglobinuria will respond to infusion of mannitol and sodium bicarbonate" • "This treatment may be effective in altering the clinical course of myoglobinuric acute renal failure"

  32. URINE ALKALINIZATION: CLINICAL STUDIES Homsi et al, 1997 • Retrospective analysis of 24 patients admitted to an ITU with a diagnosis of traumatic rhabdomyolysis (CK >500 IU/L) • Muscle injury <48 hr previously • Serum [creatinine] < 272 µmol/L

  33. URINE ALKALINIZATION: CLINICAL STUDIES Homsi et al, 1997 • 15/24 patients were treated with:  saline 0.9% (mean 204 mL/hr over 60 hr),  mannitol (mean 56 g/day), sodium bicarbonate (mean 225 mEq/day for a mean of 4.7 days) • 9/24 patients received only saline (mean 206 mL/hr over 60 hr)

  34. URINE ALKALINIZATION: CLINICAL STUDIES Homsi et al, 1997 • The initial creatine kinase activity was significantly higher in the group receiving mannitol and sodium bicarbonate • 4/15 (27%) patients died in the mannitol and sodium bicarbonate group and 2/9 (22%) patients died in the saline only group (p > 0.05)

  35. URINE ALKALINIZATION: CLINICAL STUDIES Homsi et al, 1997 • The authors claimed that progression to established renal failure could be avoided with prophylactic treatment • Once saline expansion was provided, the addition of mannitol and bicarbonate was unnecessary

  36. URINE ALKALINIZATION: CLINICAL STUDIES Brown et al, 2004 • Retrospective review of 2,083 trauma admissions to an ICU of whom 85% had abnormal CK activities (CK >520 U/L) • Renal failure (plasma creatinine > 182 µmol/L) occurred in 10% of cases • CK activity of 5,000 u/L was the lowest activity associated with renal failure

  37. URINE ALKALINIZATION: CLINICAL STUDIES Brown et al, 2004 • 382/2,083 (18%) patients had CK activities > 5,000 IU/L • 228/382 patients did not receive mannitol/sodium bicarbonate • 154/382 patients received a bolus of mannitol 0.5 g/kg and sodium bicarbonate 100 mEq diluted in 1L 0.45 normal saline

  38. URINE ALKALINIZATION: CLINICAL STUDIES Brown et al, 2004 • This was followed by mannitol 0.1 g/kg/hr and sodium bicarbonate 100 mEq (diluted in 0.45 normal saline 1L) at a rate of 2-10 mL/kg/hr • There was no significant difference in incidence of renal failure (22% vs 18%; p=0.27), dialysis (7% vs 6%; p=0.37) or mortality (15% vs 18%; p=0.37) between groups

  39. URINE ALKALINIZATION: CLINICAL STUDIES Brown et al, 2004 • The administration of mannitol and sodium bicarbonate did not prevent renal failure, dialysis or mortality if CK >5,000 U/L • "The standard of administering sodium bicarbonate/mannitol to patients with post-traumatic rhabdomyolysis should be re-evaluated"

  40. URINE ALKALINIZATION AND RHABDOMYOLYSIS-INDUCED RENAL FAILURE Conclusions • Experimental data suggest:  Administration of sodium bicarbonate to produce urine alkalinization  Volume replacement  Can reduce the likelihood of rhabdomyolysis-induced renal failure

  41. URINE ALKALINIZATION AND RHABDOMYOLYSIS-INDUCED RENAL FAILURE Conclusions • Limited clinical data suggest that:  Early volume replacement is more important than urine alkalinization  In preventing rhabdomyolysis-induced renal failure

  42. URINE ALKALINIZATION AND RHABDOMYOLYSIS-INDUCED RENAL FAILURE Conclusions • There are no adequate data in poisoned patients • Rational basis for employing early volume replacement and probably urine alkalinisation • To reduce the severity or prevent the onset of rhabdomyolysis-induced renal failure